Anti-HIV Agents
Advancements in antiretroviral therapies have downgraded HIV/AIDS from a fatal disease to a chronic condition. TRC's NRTI's, protease and integrase inhibitors can support research into much needed lower toxicity HIV drugs.
Shop nowExplore our latest catalogue of research chemicals, analytical standards and the largest global collection of pathogenic virus strains.
The boom in virology research has stimulated useful innovations, although significant threats remain. TRC provide many unique HIV and Covid relevant molecules to support your vital research.
View rangeContinuous outbreaks of established and emerging pathogens drive the need for scientific advances. That's why ATCC remains committed to providing superior biomaterials to progress your viral research.
Browse nowQuality will always be central to successful drug testing and product release. LGC Mikromol can provide the quality reference materials you need for quantitative virology API and impurity analysis.
Discover nowTRC antiviral research tools for innovation and discovery
ATCC authenticated high purity viral strains
Mikromol antiviral drug product reference materials
Antivirals and antiretrovirals are critical elements in fighting the spread of viral diseases. These include HIV/AIDS, coronaviruses that cause SARS and Covid-19, MERS, Tuberculosis, Hepatitis, and Herpes - as well as flaviviruses such as Ebola, West Nile, Zika and Dengue.
TRC provides a vast range of novel and unique compounds designed to inhibit, block and bind to new and emerging viral drug targets. Our portfolio includes research chemicals, analytical standards, bioactive molecules, natural products, APIs, impurities and metabolites, plus more than 21,000 stable isotope labelled standards.
Advancements in antiretroviral therapies have downgraded HIV/AIDS from a fatal disease to a chronic condition. TRC's NRTI's, protease and integrase inhibitors can support research into much needed lower toxicity HIV drugs.
Shop nowThe pandemic has stimulated unprecedented research, innovation and discovery. Many novel and repurposed agents from TRC’s large and diverse research chemical catalogue can support you in the fight against Covid.
Shop nowNearly 400 million people worldwide have chronic viral hepatitis, but testing of small molecules in pre-clinical models of disease could move treatment forward. Explore TRC's anti-hepatitis agents, including adefovir and ribavirin.
Shop nowThere are 130 species of herpes, spreading infections ranging from cold sores and genital herpes to chickenpox and glandular fever. TRC's uniquely large catalogue including acyclovir-d4 can help you combat these diverse pathogens.
Shop nowFlavivirus comprises numerous viruses which continue to cause many deaths and hospitalisations - including Ebola, West Nile, Yellow Fever, and Zika. TRC chemicals such as favipiravir can support your fight against these threats.
Shop nowCan’t find what you need on our website or want to discuss a specific project? Make use of TRC's custom synthesis problem-solving skills. Our 250+ chemists are up to the challenge!
Get in touchSee some recent publications citing our infectious disease products:
TRC chemicals are helping HIV research efforts
TRC research chemicals are used in a cutting-edge study demonstrating that a targeted-ARV nanoformulation dual-action mechanism could provide a multifactorial solution towards achieving a HIV functional cure.
Read the research hereTRC chemicals are being used to combat hepatitis
TRC chemicals featured in a recent study investigating cellular regulators of Hepatitis B replication - revealing a role for modulation of the enzyme CAMKII in inhibiting viral replication, useful for designing new drugs to target the HBV pathogen.
Read the research hereYour punchout session will expire in1 min59 sec.
Select "Continue session" to extend your session.